CME Planet
  • $0.00
  • Activities
    Topics
    • Acute Coronary Syndromes
    • Arrhythmia
    • Cardiometabolic Risk
    • Transthyretin Amyloid Polyneuropathy
    • Chronic Kidney Disease
    • Diabetes
    • Dyslipidemia
    • Heart Failure
    • Hypertension
    • Interventional Cardiology
    • Ischemic Heart Disease
    • Narcolepsy & OSA
    • Nephrology
    • Opiod Induced Constipation
    • Stroke
    • Hyperkalemia
    Target Audience
    • Cardiologists
    • Other Healthcare Professionals
    • Sleep Center Managers
    • Sleep Technologists
    • Nephrologist
    Credit Type
    • CE
    • CME
    Media Type
    • Audio
    • External Link
    • PDF
    • Video
  • Resources
    • News
    • Guidelines
    • Clinical Trials
    • Press Releases
  • Calendar
  • About Us
  • Contact Us
  • Log In / 
  • No Account? Register free
  • Home
  • Member
  • Login

21503_Improving the Care of Patients with Narcolepsy: Evidence-Based Strategies

Michael J. Sateia, MD and Helene A Emsellem, MD and Shalanda L. Mitchell, RPSGT, RST describe best practices in recognition, diagnosis and treatment of narcolepsy.

Narcolepsy is a chronic neurologic disorder that is often underrecognized and underdiagnosed in the clinical setting despite advances in the understanding of its etiology and pathophysiology. The diagnosis of narcolepsy is often overlooked and could be attributed to other medical or even psychiatric conditions with years of missed diagnosis. Therefore, sleep technologists can aid physicians in the diagnosis of patients with narcolepsy, thereby truly helping narcoleptics lead better and healthier lives.

Narcolepsy is a clinical syndrome characterized by excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hallucinations, automatic behaviors, and fragmented or disrupted sleep. Symptoms often start in childhood or adolescence, but can occur later in life. Narcolepsy is a substantially disabling disease with profound physical, mental, and social effects. If left untreated, narcoleptics risk falling asleep any time during the day, emphasizing the importance of controlling the condition for individuals who regularly operate dangerous machinery or rely on motor vehicles for regular transportation. The treatment of narcolepsy is aimed at the different symptoms that the patient manifests. Unfortunately, lifestyle changes are rarely sufficient to adequately control the symptoms of narcolepsy, and most patients require life-long medication to cope with the debilitating effects of this disorder. Pharmacologic treatment has been highly recommended and supported by well-designed research that shows its effectiveness. Pharmacologic therapies for narcolepsy include those to treat EDS and cataplexy.

In this program, experts in narcolepsy management will describe best practices in the recognition and diagnosis including definitions from the DSM-5 and ICSD-3 guidelines, diagnostic tests available to detect narcolepsy, treatment options and associated clinical efficacy and safety data. Short lecture presentations will be followed by one case study presentation with panel discussion.

Login to your Account


No Account Yet? Register Here!

Forgot your password?

or

Login or Register with

Sign in with twitter
Sign in with google


Activity Categories

  • Topics
    • Acute Coronary Syndromes ( 9 )
    • Arrhythmia ( 1 )
    • Cardiometabolic Risk ( 13 )
    • Transthyretin Amyloid Polyneuropathy ( 1 )
    • Chronic Kidney Disease ( 2 )
    • Diabetes ( 7 )
    • Dyslipidemia ( 8 )
    • Heart Failure ( 14 )
    • Hypertension ( 1 )
    • Interventional Cardiology ( 9 )
    • Ischemic Heart Disease ( 3 )
    • Narcolepsy & OSA ( 15 )
    • Nephrology ( 1 )
    • Opiod Induced Constipation ( 1 )
    • Stroke ( 5 )
    • Hyperkalemia ( 1 )
  • Target Audience
    • Cardiologists (5)
    • Other Healthcare Professionals (5)
    • Sleep Center Managers (5)
    • Sleep Technologists (5)
    • Nephrologist (5)
  • Credit Type
    • CE (2)
    • CME (2)
  • Media Type
    • Audio (4)
    • External Link (4)
    • PDF (4)
    • Video (4)

Future Live Events

2026 American Association of Heart Failure Nurses (AAHFN)
Jun 24, 2026

(2026 AAHFN) Maintaining RAAS Inhibition and Managing Hyperkalemia: Expert Insights into Best HF Patient Care
Jun 24, 2026

(2026 AAHFN) New Opportunities with Mineralocorticoid Receptor Antagonists to Improve Outcomes in Heart Failure
Jun 25, 2026

(2026 AAHFN) Practical Management of Transthyretin Cardiac Amyloidosis
Jun 25, 2026

2026 San Diego Heart Failure Summer Symposium (SDHF)
Jul 09, 2026

2026 Heart Failure Management (HFM)
Jul 16, 2026

2026 American Academy of Family Physicians FMX (AAFP)
Oct 20, 2026

Sign Up For Our Newsletter

About

CMEPlanet.com is owned and operated by Voxmedia International.

Voxmedia LLC is an ACCME-accredited provider offering independent medical education services spanning graphic design, web and print production, logistical services, and scientific content development. Voxmedia produces CME symposia, live meetings, and multimedia educational products.

Voxmedia LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Site Navigation

  • Activities
  • News
  • Calendar
  • About Us
  • Contact Us

Information

  • About us
  • Privacy Policy
  • Cookies Policy
  • Consent Preferences
  • Terms and Conditions

Newsletter

Sign up to our newsletter!

© 2026  CMEPlanet. All Rights Reserved.

Site development by Developed by Hop Studios, Vancouver Web design and development shop Hop Studios

Log In

New Customer?

Create an Account